ABPath Pediatric Pathology common mistakes
ABPath Pediatric Pathology · Understand the traps and how to avoid them.
When given a fetal or neonatal autopsy scenario, committing to a single cause of death before systematically listing and excluding the major categories (placental, infectious, genetic, malformation, metabolic).
Candidates anchor on the most visually dramatic finding (e.g., a single malformation) and stop the differential, mirroring the way cases are often presented in teaching files where one diagnosis is emphasized.
What to do instead
Before finalizing, write an explicit category checklist (placenta, infection, genetics, structural, metabolic, iatrogenic) and document why each is included or excluded; only then rank the cause of death.
Misclassifying the timing of a fetal demise (antepartum vs intrapartum vs postmortem changes) based on a single finding such as maceration or skin slippage without integrating placental, visceral, and skeletal findings.
Timing criteria overlap and candidates memorize isolated features rather than the constellation and its temporal sequence.
What to do instead
Build a timing table linking each finding (maceration stages, mummification, lung/renal histology, skin changes) to an estimated interval, and require at least three concordant findings before assigning a time of death.
Confusing placental lesions of maternal versus fetal origin and their clinical implications (e.g., maternal vascular malperfusion vs fetal vascular malperfusion vs maternal floor infarction/massive perivillous fibrin deposition).
Lesion names sound similar and candidates learn them as a list rather than as patterns tied to villous architecture and clinical associations.
What to do instead
For each lesion, state the villous/vascular pattern, the side of origin, and the associated clinical outcome; practice sorting a mixed list of lesions into maternal, fetal, and inflammatory categories.
Attributing a congenital anomaly to a known syndrome or association without verifying that the required criteria are met, or labeling a sequence as a syndrome.
Pattern recognition is rewarded in training, so candidates jump to a named entity and skip the definitional check.
What to do instead
Memorize the defining criteria for the major pediatric entities (e.g., VACTERL, CHARGE, Potter sequence, Pierre Robin sequence) and, on each case, explicitly list which criteria are present and absent before naming the entity.
Missing the distinction between chromosomal, single-gene, and imprinting/methylation disorders when interpreting cytogenetic and molecular results, leading to the wrong test recommendation.
Candidates treat all genetic tests as interchangeable and do not map the clinical phenotype to the appropriate assay.
What to do instead
Create a phenotype-to-test decision map (karyotype, FISH, CMA, methylation, sequencing) and justify the chosen test by the suspected mechanism; state what each test cannot detect.
Over- or under-interpreting immunohistochemistry in pediatric tumors (e.g., treating a single positive marker as diagnostic in small round blue cell tumors) without a panel-based, lineage-aware approach.
Individual markers are memorable and candidates rely on one 'key' stain rather than the expected co-expression and exclusion patterns.
What to do instead
For each major pediatric tumor category, list the expected positive panel, the expected negative panel, and the classic pitfalls; require at least two concordant markers before committing to a lineage.
Failing to apply pediatric-specific reference intervals and age-dependent normal values in laboratory interpretation (hematology, chemistry, coagulation, transfusion thresholds).
Adult reference ranges are overlearned and candidates apply them reflexively to neonates and children.
What to do instead
Before interpreting any pediatric lab value, state the age-specific reference interval being used and note how the value would be classified in an adult versus a child.
Misapplying transfusion medicine principles in neonates and fetuses (e.g., ignoring maternal antibody status, irradiation/leukoreduction requirements, or exchange transfusion indications).
General adult transfusion rules are well rehearsed, while the special neonatal and fetal requirements are less frequently encountered and easily overlooked.
What to do instead
Maintain a short neonatal transfusion checklist (antibody screen and maternal history, product modification, volume and threshold) and run every scenario through it.
Treating perinatal infection diagnoses as serology-only or histology-only, failing to integrate maternal serology, placental findings, and fetal/neonatal tissue findings into a single interpretation.
Each data source is taught in a separate rotation, so candidates do not practice synthesizing them.
What to do instead
For each TORCH-type agent, write the expected maternal serology pattern, placental findings, and fetal/neonatal tissue findings side by side, and practice combined-interpretation questions.
Neglecting laboratory management and quality assurance content (validation, proficiency testing, error investigation, turnaround, and accreditation requirements) because it feels non-clinical, and answering from intuition.
This domain receives less study time and candidates assume common sense suffices, but the exam tests specific regulatory and quality frameworks.
What to do instead
Build a one-page framework covering method validation, QC rules, proficiency testing, root-cause analysis, and accreditation standards, and apply it to short scenario questions until the structure is automatic.